SUNNYVALE, Calif., Jan. 14 /PRNewswire-FirstCall/ -- Accuray Incorporated
(Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced
that it will report results for its second quarter fiscal year 2009, ending
December 27, 2008, on Thursday, January 29, 2009 after the market closes.
A conference call to review the results will begin at 2:00 p.m. PST / 5:00
p.m. EST and will be hosted by Euan S. Thomson, Ph.D., president and chief
executive officer, and Derek Bertocci, senior vice president and chief
financial officer.
The conference call dial-in numbers are 1-866-379-2019 (USA) or
1-706-634-1525 (International), Conference ID: 80572858 In addition, a
dial-up replay of the conference call will be available beginning January 29,
2009 at 5:00 p.m. PST / 8:00 p.m. EST and ending on January 31, 2009. The
replay telephone number is 1-800-642-1687 (USA) or 1-706-645-9291
(International), Conference ID: 80572858.
A live webcast of the call will also be available from the Investor
Relations section of the corporate Web site at http://www.accuray.com. A
webcast replay can be accessed on the corporate Web site beginning Thursday,
January 29, 2009 at approximately 5:00 p.m. PST / 8:00 p.m. EST. The replay
will remain available until Accuray announces its results for the third
quarter of fiscal 2009, ending March 28, 2009.
About the CyberKnife(R) Robotic Radiosurgery System
The CyberKnife Robotic Radiosurgery System is the world's only robotic
radiosurgery system designed to treat tumors anywhere in the body
non-invasively. Using continual image guidance technology and computer
controlled robotic mobility, the CyberKnife System automatically tracks,
detects and corrects for tumor and patient movement in real-time throughout
the treatment. This enables the CyberKnife System to deliver high-dose
radiation with pinpoint precision, which minimizes damage to surrounding
healthy tissue and eliminates the need for invasive head or body stabilization
frames.
About Accuray
Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a
global leader in the field of radiosurgery dedicated to providing an improved
quality of life and a non-surgical treatment option for those diagnosed with
cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery
System, which extends the benefits of radiosurgery to include extracranial
tumors, including those in the spine, lung, prostate, liver and pancreas. To
date, the CyberKnife System has been used to treat more than 50,000 patients
worldwide and currently more than 150 systems have been installed in leading
hospitals in the Americas, Europe and Asia. For more information, please visit
http://www.accuray.com.
SOURCE Accuray Incorporated
01/14/2009
CONTACT: Investors, Tom Rathjen, Vice President, Investor Relations, +1-
408-789-4458, trathjen@accuray.com, or Media, Stephanie Tomei, Manager, Public
Relations, +1-408-789-4234, stomei@accuray.com
Web site: http://www.accuray.com/
